, Volume 10, Issue 5, pp 365-371
Date: 16 Oct 2008

Modern approaches to treating chronic myelogenous leukemia

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Over the past decade, the treatment of chronic myelogenous leukemia (CML) has gone through significant advances. Once an invariably fatal disease without stem cell transplant, it has since become one of the most manageable hematologic malignancies with good long-term outcomes. However, patients are not cured and require life-long treatment, and unfortunately, some of these patients develop resistant disease that progresses despite our best treatments. As our understanding of CML continues to grow, the repertoire of drugs available for successful treatment also increases. The following review discusses the current and future therapies for CML.